BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19429848)

  • 1. Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.
    Fernandez HH; See RH; Gary MF; Bowers D; Rodriguez RL; Jacobson C; Okun MS
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):223-7. PubMed ID: 19429848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nondemented Parkinson disease patients: is cognitive performance associated with depressive difficulties?
    Klepac N; Trkulja V; Relja M
    Cogn Behav Neurol; 2008 Jun; 21(2):87-91. PubMed ID: 18541984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief cognitive assessment in the early stages of Parkinson disease.
    Bugalho P; Vale J
    Cogn Behav Neurol; 2011 Dec; 24(4):169-73. PubMed ID: 22045168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apathy and depression in Parkinson disease.
    Oguru M; Tachibana H; Toda K; Okuda B; Oka N
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):35-41. PubMed ID: 20015839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms.
    Klepac N; Hajnsek S; Trkulja V
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):15-26. PubMed ID: 19996416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clock drawing interpretation scale (CDIS) and neuro-psychological functions in older adults with mild and moderate cognitive impairments.
    Colombo M; Vaccaro R; Vitali SF; Malnati M; Guaita A
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():39-48. PubMed ID: 19836615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does laterality of motor impairment tell us something about cognition in Parkinson disease?
    Cooper CA; Mikos AE; Wood MF; Kirsch-Darrow L; Jacobson CE; Okun MS; Rodriguez RL; Bowers D; Fernandez HH
    Parkinsonism Relat Disord; 2009 May; 15(4):315-7. PubMed ID: 18793864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
    Harwood DG; Sultzer DL; Wheatley MV
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untreated depressive symptoms among cognitively-intact, community dwelling Filipino patients with Parkinson disease.
    Go CL; Rosales RL; Joya-Tanglao M; Fernandez HH
    Int J Neurosci; 2011 Mar; 121(3):137-41. PubMed ID: 21126107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory and executive function impairment predict dementia in Parkinson's disease.
    Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance.
    Scholtissen B; Verhey FR; Adam JJ; Weber W; Leentjens AF
    Clin Neuropharmacol; 2006; 29(5):276-85. PubMed ID: 16960473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.